SureTrader Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

ONVO RSS Feed
Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Granddadx6
Search This Board:
Last Post: 7/28/2016 12:53:39 PM - Followers: 319 - Board type: Free - Posts Today: 0
WELCOME TO THE ORGANOVO BOARD


 
     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

COMPANY PROFILE via YouTube
http://www.youtube.com/watch?feature=player_embedded&v=-A-uH15bQZw

 
ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014


IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994


For all the latest company information, details, news, please visit http://www.organovo.com

 
Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:

Science

Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.

 

World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

 

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

http://www.invetech.com.au/portfolio/life-sciences/3d-bioprinter-world-first-print-human-tissue/
http://techli.com/2012/07/organovo-bioprinting/#.
https://www.youtube.com/watch?v=1O3c3pUg0L8 (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ONVO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ONVO News: Notice of Effectiveness (effect) 07/28/2016 06:01:40 AM
ONVO News: Securities Registration (section 12(b)) (8-a12b) 07/26/2016 08:11:37 AM
ONVO News: Current Report Filing (8-k) 07/26/2016 08:06:26 AM
ONVO News: Post-effective Amendment to Registration Statement (pos Am) 07/20/2016 08:12:54 AM
ONVO News: Current Report Filing (8-k) 07/20/2016 08:09:30 AM
PostSubject
#9373  Sticky Note ONVO 8K---EXCHANGE CHANGE; Granddadx6 07/26/16 08:13:34 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9397   Exactly. You're welcome. Granddadx6 07/28/16 12:53:39 PM
#9396   Basically a formality. Thanks! BuckeyeStocks 07/28/16 08:42:42 AM
#9395   Here ya go; Granddadx6 07/28/16 07:57:20 AM
#9394   I received this in an email an hour BuckeyeStocks 07/28/16 07:08:30 AM
#9393   I'll drink to that! ONVO----CHEERS!! Granddadx6 07/27/16 06:40:56 PM
#9392   Hope to see many more HOYs for years tyfoidhana 07/27/16 06:27:05 PM
#9391   If we can break and hold, it sets bettyfordallstar 07/27/16 06:12:31 PM
#9390   Break 52 week high coming tomorrow hwpbnj 07/27/16 04:02:09 PM
#9389   Looks like ONVO might hit a new HOY RandolRocketman 07/27/16 03:47:11 PM
#9388   until the line about 3D and Stratasys it uksausage 07/27/16 08:30:18 AM
#9387   http://www.mynewsdesk.com/in/pressreleases/research-providing-in-depth-analysis- BuckeyeStocks 07/26/16 09:11:05 PM
#9386   Ok again, I thank you 61 times for ddbl_our_buck 07/26/16 02:46:58 PM
#9385   ..or the Mighty Quinn, by Manfred Mann. ddbl_our_buck 07/26/16 02:15:56 PM
#9384   LOL! You must be as ancient as I Granddadx6 07/26/16 01:19:45 PM
#9383   Okay then, we need to hold these levels, ddbl_our_buck 07/26/16 01:09:06 PM
#9382   JMO---More eyes of investors in new technologies will Granddadx6 07/26/16 12:55:01 PM
#9381   No ~ imo, em ddbl_our_buck 07/26/16 12:53:57 PM
#9380   Last time they "uplisted" from the OTC to RandolRocketman 07/26/16 12:51:18 PM
#9379   Tasty prediction.. Em ddbl_our_buck 07/26/16 12:50:01 PM
#9378   Organovo Holdings Shares Rise; To Start Trading on RandolRocketman 07/26/16 12:49:49 PM
#9377   Way to go Murph!!! The light just ddbl_our_buck 07/26/16 09:18:42 AM
#9376   Murphy's statement within the press release gives the BuckeyeStocks 07/26/16 09:04:15 AM
#9375   Doing a little light reading to research the BuckeyeStocks 07/26/16 08:51:29 AM
#9374   I'm not sure what the rationale is behind BuckeyeStocks 07/26/16 08:42:40 AM
#9373   ONVO 8K---EXCHANGE CHANGE; Granddadx6 07/26/16 08:13:34 AM
#9372   Upcoming Webinar: Link to register follows. RandolRocketman 07/25/16 04:23:11 PM
#9371   Zacks Investment Research, Inc. upgrades ORGANOVO HOLDINGS INC RandolRocketman 07/25/16 08:32:50 AM
#9370   I totally agree, skin is most likely bettyfordallstar 07/24/16 10:33:36 PM
#9369   Since we know L'oreal, are in business with RandolRocketman 07/24/16 09:27:05 PM
#9368   The possibilities are endless. I have a bettyfordallstar 07/21/16 02:10:20 AM
#9367   I would not be terribly surprised to see RandolRocketman 07/20/16 11:55:25 PM
#9366   They apparently weren't kidding about not needing to RandolRocketman 07/20/16 11:29:00 PM
#9365   I second that opinion and am doubling my tyfoidhana 07/20/16 08:58:12 PM
#9364   Much more. Strong recovery off the January lows Granddadx6 07/20/16 05:00:13 PM
#9363   Thanks. Organovo has gotten a little more Windbag1014 07/20/16 04:35:21 PM
#9362   Nice to read from you WB1014. GL! Granddadx6 07/20/16 04:13:57 PM
#9361   Robust sales footprint. Windbag1014 07/20/16 02:50:03 PM
#9360   Robust sales?!? Proven where?!? RallyTheMarket 07/20/16 02:46:36 PM
#9359   Any guesses what happens to this when they RandolRocketman 07/20/16 02:19:22 PM
#9358   Yep. Rally in Market. Nice dshade 07/20/16 01:56:40 PM
#9357   ONVO---AS REAL AS IT GETS!----GLTU/A Granddadx6 07/20/16 01:05:26 PM
#9356   The best part of the announcement was the BuckeyeStocks 07/20/16 11:42:29 AM
#9355   Yep. The future has arrived. dshade 07/20/16 11:25:49 AM
#9354   ONVO ~ No more disgust trades! Now ddbl_our_buck 07/20/16 10:53:03 AM
#9353   Organovo on Track to Commercialize Kidney Tissue; Company BuckeyeStocks 07/20/16 10:22:02 AM
#9352   ONVO---GLTA! Granddadx6 07/20/16 10:21:34 AM
#9351   BRIEF-Organovo on track to commercialize kidney tissue in RandolRocketman 07/20/16 10:15:04 AM
#9350   Holy crap! RandolRocketman 07/20/16 10:13:09 AM
#9349   I do want to backpeddle on one thing PennyWorld 07/19/16 11:46:55 PM
#9348   Seven (7) red candles later and technically the JrDelane 07/15/16 07:32:28 PM
PostSubject